The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.Blood transfusion = Trasfusione del sangue · 2020
   Review
2. ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention.European heart journal supplements : journal of the European Society of Cardiology · 2017
   Article
3. ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.European heart journal supplements : journal of the European Society of Cardiology · 2017
   Article
4. How we treat bleeding associated with direct oral anticoagulants.Blood transfusion = Trasfusione del sangue · 2016
   Review
5. The evolution of anticoagulant therapy.Blood transfusion = Trasfusione del sangue · 2016
   Review
6. Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy.Case reports in critical care · 2016
   Article
7. The use of novel oral anticoagulants: the debate continues!Blood transfusion = Trasfusione del sangue · 2015
   Article

Corrections and comments

• Commented on by
  The use of novel oral anticoagulants: the debate continues!2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as